Circadian rhythm disruption in myalgic encephalomyelitis/chronic fatigue syndrome: implications for the post-acute sequelae of COVID-19
Clinical trial data for tirzepatide tells a similar story, with lean mass accounting for roughly 25% of total weight lost
Their use is rising rapidly, and with good reason: These medications have been shown to reduce blood sugar, improve fatty liver, GERD, sleep apnea, osteoarthritis, blood pressure, triglycerides, major adverse cardiovascular events, and even show potential benefits for conditions like alcohol use disorder (Mozaffarian et al., 2025
Cellulite often becomes more prevalent with aging and weight gain, however, this condition affects people of all ages, regardless of body-type or fitness level
Consider this: a Phase 2 trial revealed that beginning treatment with microdoses of 1 mg led to noticeable improvements in both body mass and HbA1c levels